Searched for
GLAND PHARMA NEWS
Honasa Consumer, 6 other stocks hit 52-week highs, rally up to 35% in a monthDespite weakness in the broader market, seven BSE 500 stocks including Honasa Consumer, Aegis Logistics and Gland Pharma scaled fresh 52-we...- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- Gland Pharma shares rally 6% as brokerages lift ratings, target prices; here's whyGland Pharma shares surged after strong Q1 results and positive commentary from brokerages citing a turnaround at its European unit Cenexi....
- Gland Pharma shares rise 5% on receiving US FDA approval for vitamin K deficiency injectableGland Pharma shares rose after receiving FDA approval for phytonadione injectable emulsion, a product used for coagulation disorders. Despi...
- Buy Gland Pharma, target price Rs 2440: Motilal OswalGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 34712.36 Crore) operating in Pharmaceut...
- Fosun is said to plan block deals to pare stake in Gland PharmaThe listed arm of billionaire Guo Guangchang’s Fosun International Ltd. holds about 58% of Gland Pharma, which has a market value 303 billi...
- Gland Pharma shares fall 6% as ex-promoter likely sells stake in block dealsShares of Gland Pharma dropped 6% to Rs 1,745 on BSE as entities related to ex-promoter Dr Ravi Penmetsa sold 5.5% equity. Large block deal...
- Two entities likely to sell 4.4% stake in Gland Pharma via block deals: ReportNicomac Machinery and RP Advisory Services are looking at raising Rs 1,400 crore through the sale, and have set the floor price for the sam...
- Buy Gland Pharma, target price Rs 2240: Motilal OswalGland Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Other Operating Revenue and Export Incentives fo...
- Gland Pharma shares climb over 6% post Q2 results. Should you buy or sell?Meanwhile, the company's earnings before interest, taxes, depreciation and amortization (EBITDA) came in at Rs 320.5 crore, up from Rs 297 ...
- Buy Gland Pharma, target price Rs 1920: Motilal OswalGland Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Other Operating Revenue and Export Incentives fo...
- Gland Pharma shares tank 19%, hit 52-week low as Q4 earning weighsGland Pharma shares reached a 52-week low of Rs 861 on May 24th, falling for the fifth consecutive day. The fall comes after the company re...
- Fosun drops plan to sell stake in Gland Pharma: ReportShares of Gland Pharma were up 0.8% at 1,360 rupees as of 9:50 a.m. IST. They have plunged 28% since November end, when Bloomberg News had ...
- Fosun Said to Mull Sale of India’s $3.6 Billion Gland PharmaA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
- Gland Pharma rallies 9% as Fosun mulls selling controlling stake in firmA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
- Gland Pharma loses 24% of its value in 3 days. What's spooking investors?Gland Pharma said revenue from its core markets of the US, Europe, Canada and Australia grew by 3 per cent to Rs 747.5 crore in the second ...
- Smartkarma Research: APAC Healthcare Series - Top picks are poised for multi-year growthGland Pharma’s near-term focus remains on establishing a strong portfolio of complex injectables. The company is working on development of ...
- Gland Pharma’s Rs 6,480 crore IPO sails through, gets 2.06x bidsProgressive Share Brokers said that sentiment towards the IPO has dampened a bit due to Chinese investments as well as from the fact that S...
- Gland Pharma IPO: Analysts recommend subscribing, but flag stretched valuationsGland Pharma’s IPO is India’s largest pharmaceutical IPO ever.
- Grey market premium fizzles out for Gland Pharma after fixing price bandThe Gland Pharma IPO, India’s largest from the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an offer...
Load More
